Epclusa Approved for Chronic Hepatitis C

TUESDAY, June 28, 2016 — The combination drug Epclusa has been approved by the U.S. Food and Drug Administration to treat the six major strains of chronic hepatitis C virus (HCV).
Epclusa combines sofosbuvir, FDA-approved in 2013, and the new drug…
Source: Topamax